Company Filing History:

9 out of 9

Molecular Geriatrics Corporation

patents

8 out of 4,177

Abbott Laboratories Corporation

patents

1 out of 1

Molecualr Geriatrics Corporation

patent

Years Active: 1986-2007

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7173132 - Certain substituted 1-aryl-3-piperazine-1'-yl propanones (2007-02-06),

2. 6864062 - Purified antigen for Alzheimer's disease and methods of obtaining and using same (2005-03-08),

3. 6306857 - Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanones (2001-10-23),

4. 6228878 - Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanones (2001-05-08),

5. 6214994 - Certain substituted 1-aryl-3-piperazin-1′-yl propanones (2001-04-10),

6. 6075026 - Certain substituted 1-aryl-3-piperazin-1'-yl propanones (2000-06-13),

7. 5968936 - Methods for treating or preventing Alzheimer's Disease using substituted (1999-10-19),

8. 5705501 - Certain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's (1998-01-06),

9. 5693804 - Substituted 1-aryl-3-piperazin-1'-yl propanones (1997-12-02),

10. 5658909 - Certain substituted 1-aryl-3-piperazin-1'-yl propanones to treat (1997-08-19),

11. 5559144 - Furyl and thienyl alkynyl-N-hydroxy urea derivatives (1996-09-24),

12. 5476873 - Acetylene derivatives having lipoxygenase inhibitory activity (1995-12-19),

13. 5389638 - Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake (1995-02-14),

14. 5326776 - Angiotensin II receptor antagonists (1994-07-05),

15. 5250548 - Angiotensin II receptor antagonists (1993-10-05),

Title: The Innovative Journey of Daniel Joseph Kerkman

Introduction:

Daniel Joseph Kerkman, a prolific inventor, has made significant contributions in the field of pharmaceuticals and Alzheimer's disease research. With a location in Lake Villa, IL (US), he has been the mind behind 18 patents and continues to drive advancements in the industry.

Latest Patents:

Among his latest patents is the development of "Certain substituted 1-aryl-3-piperazine-1'-yl propanones," a compound designed to address specific medical needs. Additionally, his work on "Purified antigen for Alzheimer's disease" showcases his commitment to enhancing diagnostic tools for this prevalent neurological condition.

Career Highlights:

Having worked at Molecular Geriatrics Corporation and Abbott Laboratories, Kerkman has demonstrated his expertise in pharmaceutical research and development. His innovative approach to problem-solving has led to groundbreaking solutions in the medical field.

Collaborations:

Throughout his career, Kerkman has collaborated with esteemed professionals such as John F DeBernardis and Raymond Paul Zinkowski. These collaborations have further enriched his projects and led to successful outcomes in the industry.

Conclusion:

In conclusion, Daniel Joseph Kerkman's dedication to innovation in pharmaceuticals and Alzheimer's disease research has solidified his position as a visionary inventor. His patents and collaborations stand as a testament to his profound impact on the field, paving the way for advancements that benefit society as a whole.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.